Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 3 |
2012 | 1 |
2013 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.
Hum Mutat. 2013 Jan;34(1):149-56. doi: 10.1002/humu.22176. Epub 2012 Oct 4.
Hum Mutat. 2013.
PMID: 22887727
Free PMC article.
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, Markt SC, Freedman M, Pomerantz M, Lee GM, Rana H, Börnigen D, Rebbeck TR, Huttenhower C, Eeles RA, Stanford JL, Consortium P, Berndt SI, Claessens F, Sørensen KD, Park JY, Vega A, Usmani N, Mucci L, Sweeney CJ.
Wang V, et al.
Prostate. 2021 Jul;81(10):683-693. doi: 10.1002/pros.24148. Epub 2021 May 6.
Prostate. 2021.
PMID: 33956343
Free PMC article.
Item in Clipboard
Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.
Salinas CA, Kwon EM, FitzGerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL.
Salinas CA, et al.
Am J Epidemiol. 2010 Sep 1;172(5):578-90. doi: 10.1093/aje/kwq175. Epub 2010 Aug 5.
Am J Epidemiol. 2010.
PMID: 20688905
Free PMC article.
Item in Clipboard
Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.
Kwon EM, Salinas CA, Kolb S, Fu R, Feng Z, Stanford JL, Ostrander EA.
Kwon EM, et al.
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):923-33. doi: 10.1158/1055-9965.EPI-10-0994. Epub 2011 Mar 23.
Cancer Epidemiol Biomarkers Prev. 2011.
PMID: 21430300
Free PMC article.
Item in Clipboard
Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL.
FitzGerald LM, et al.
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1196-203. doi: 10.1158/1055-9965.EPI-10-1299. Epub 2011 Apr 5.
Cancer Epidemiol Biomarkers Prev. 2011.
PMID: 21467234
Free PMC article.
Clinical Trial.
Item in Clipboard
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.
Lin DW, FitzGerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, Wiklund F, Stattin P, Isaacs WB, Xu J, Ostrander EA, Feng Z, Grönberg H, Stanford JL.
Lin DW, et al.
Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1928-36. doi: 10.1158/1055-9965.EPI-11-0236. Epub 2011 Aug 16.
Cancer Epidemiol Biomarkers Prev. 2011.
PMID: 21846818
Free PMC article.
Item in Clipboard
Cite
Cite